Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain
REVLOC
Evaluation of the Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain. A Randomized Controlled Trial Using a Modified ZELEN Method
1 other identifier
interventional
122
1 country
1
Brief Summary
Chronic low back pain and sciatica in adults represent a major medical and economic problem. During the chronic back pain (persisting continuously over 3 months), therapeutic responses to conventional pharmacologic type are often ineffective and the impact of pain is often heavy in terms of disability, social and professional avulsion and loss of quality of life. This failure has led in recent years to propose innovative strategies such as application of relaxation therapy techniques. An example is a virtual reality which is a technology to immerse someone in a 3D virtual environment. Our hypothesis is that the hypnotic suggestion combined with virtual reality can be effective on chronic pain. The main purpose is to measure the impact on the intensity of pain at 4 months after using of a new method for virtual environment, mimicking the colors from low to high frequencies (World Patent Filed, WO2007/057601) in patients with chronic disabling low back pain and sciatica resistant to therapeutic drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Jun 2011
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2011
CompletedStudy Start
First participant enrolled
June 1, 2011
CompletedFirst Posted
Study publicly available on registry
August 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedNovember 20, 2025
October 1, 2025
3.4 years
May 30, 2011
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Low back pain in the last 48 hours
Low back pain in the last 48 hours assessed on a numerical pain scale (0 - 100) at 4 months
4 months
Secondary Outcomes (4)
Disability (Quebec questionnaire)
1 month and 4 months
Anxiety and depression (HAD)
1 month and 4 months
Quality of life (SF-12)
at 1 and 4 months
Overall serum antioxidant defenses
at inclusion (baseline) and 1 month after inclusion
Study Arms (2)
virtual reality
EXPERIMENTALusual care
OTHERInterventions
3 sessions of immersion in a virtual reality 3D environment of 17 minutes per week for 4 consecutive weeks
Eligibility Criteria
You may qualify if:
- More than 18 and less than 60 years (inclusive)
- Chronic low back pain or chronic sciatica (between 3 months and 1 year of the current episode), without neurological deficit (low back pain more important than sciatica), common spinal origin, resistant to medical therapy, and the numerical pain scale \> 30/100
- Written informed consent
- Membership or beneficiary of an insurance
You may not qualify if:
- Low back pain related to a spinal infectious disease, inflammatory, neoplasia, osteodystrophic, malformative and traumatic.
- Deficit sciatica (motor weakness and / or sensory)
- Low back pain secondary to failure of spinal intervention.
- Co-existence of pain of another etiology.
- Seizures.
- Psychiatric disorder, uncontrolled.
- Visual disturbances (significant decrease in visual acuity without correction possibility, problems with re-cognition of color, visual field loss).
- Sick leave over 1 year
- Pregnant women
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- NEUROVIRTUALcollaborator
- URC-CIC Paris Descartes Necker Cochincollaborator
Study Sites (1)
Cochin Hospital
Paris, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serge POIRAUDEAU, MD, PhD
Cochin Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2011
First Posted
August 2, 2011
Study Start
June 1, 2011
Primary Completion
November 1, 2014
Study Completion
April 1, 2015
Last Updated
November 20, 2025
Record last verified: 2025-10